Skip to main content
Premium Trial:

Request an Annual Quote

University of Liverpool's Centre for Genomic Research Named Agilent CSP for SureSelect

NEW YORK (GenomeWeb News) – Agilent Technologies today announced the University Liverpool's Centre for Genomic Research has become the UK's first Certified Service Provider for the SureSelect Target Enrichment System for next-generation sequencing.

The center is a high-throughput sequencing facility and provides genomic data generation, analysis, and interpretation. It has performed research using genomic technologies and data analysis for more than a decade with projects focused on metagenomics, plant and animal studies, cancer genomics, and human genetics.

"We have relied on SureSelect in our research efforts to produce consistent results that we and our collaborators can be confident in," Andy Cossins, head of the Institute of Integrative Biology and co-director of the Centre for Genomic Research, said in a statement. "Achieving certified status is an important step for the CGR and will allow us to expand our sequencing leadership."

The center participated in comprehensive on-site training and passed a set of requirements to demonstrate expertise and skill, Agilent said.

SureSelect was introduced in 2009 and now includes more than 21 products in its portfolio, the Santa Clara, Calif.-based firm said.

The Scan

Harvard Team Report One-Time Base Editing Treatment for Motor Neuron Disease in Mice

A base-editing approach restored SMN levels and improved motor function in a mouse model of spinal muscular atrophy, a new Science paper reports.

International Team Examines History of North American Horses

Genetic and other analyses presented in Science find that horses spread to the northern Rockies and Great Plains by the first half of the 17th century.

New Study Examines Genetic Dominance Within UK Biobank

Researchers analyze instances of genetic dominance within UK Biobank data, as they report in Science.

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.